NOS3 and metabolic syndrome: The salient features cohesive to this thesis have illuminated the following: the augmentation of NO secretion via increase in expression and/or activity of eNOS; abatement of ROS levels through suppression of oxidant enzymes and an equilibrium shift toward increased expression of anti-oxidative enzymes and related molecules; inhibition of ACE and dyslipidemia.